Skin cancer

Home
»
Skin cancer

Latest Comments

Great discussion. The Mariano family is a national asset. Rare treat to hear these two gents discuss rare earths.... - Byron King

REI, your comment is accurate and is a forewarning of what anyone that is not driven by an American CEO should prepare for. I tell... - Tracy Weslosky

The big question for niche RE miners is, to what degree will the US Biden Admin' allow new mining permits vs going to friendly bor... - Rare Earths Investor

where is the AIDEA funding? ucore has been stating AIDEA are behind them for 8 yrs, but still no money for an SMC (forget Bokan ... - joe o

Cix seems to be going nowhere, just like rapid SX from ucore and reemf tech they are trying. Seems like SX isn’t going anywhere,... - Joe o

As so many things these days are part of war preparation, I think the location choice is part of that, too, What use are all the h... - Ally Hauptmann-Gurski

Over 50% of Tin is used for soldering electronics You didn’t mention that I don't trust your list #Fail... - Jsaw

This is to confirm that Amanda has responded and the responses are listed above.... - Tracy Weslosky

Hi Bob and Jack, You called it - critical mineral 51 should be the supply/value chains to actually extract, purify, and process t... - Nick Pingitore

Nick It's even worse than you think. Last time I looked there was only one producer of tungsten rod used in armor piercing ammuni... - Jack Lifton

Tungsten – the other critical metal and a way to play it

July 01, 2022

Mike Druhan of MedX Health on the Launch of Its Teledermatology Screening Platform in the UK

Tracy Weslosky · March 09, 2022

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services at MedX Health Corp. (TSXV: MDX) about MedX […]

Mike Druhan of MedX Health on the launch of its game changing DermSecure® Teledermatology platform

Tracy Weslosky · January 27, 2022

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services at MedX Health Corp. (TSXV: MDX) […]

June 29, 2022
China may be a good Bond villain, but rare earths experts ar ...
June 29, 2022
Global changes coming in the rare earths and critical materi ...
June 28, 2022
Jack Lifton talks with Dr. Anthony Mariano, “the most seni ...
June 28, 2022
Rare Earths and the Challenges of Building a Domestic EV Mat ...
June 27, 2022
Brent Willis of Voyageur Pharmaceuticals on securing a domes ...
June 27, 2022
Gold company Presidents and CEOs talk about the return of go ...
June 24, 2022
Byron W King talks to Energy Fuels and Ur-Energy about rampi ...
June 23, 2022
Dev Randhawa of Fission 3.0 talks about US reliance on Russi ...
June 23, 2022
The Uranium Bull in the Room – Why the Excitement is Back ...
June 23, 2022
Leading critical materials CEOs discuss the rising world dem ...
June 22, 2022
Peter Cashin of Imperial Mining talks about scandium’s imp ...
June 21, 2022
Peter Cashin on the “earth shattering” PEA for Imperial ...

Mike Druhan on MedX Health gaining revenue traction as it commercially launches its teledermatology platform

Mario Drolet · January 26, 2022

In a recent InvestorIntel interview, Mario Drolet spoke with Mike Druhan, President of Dermatology Services at MedX Health Corp. (TSXV: […]

Mike Druhan and Naman Demaghlatrous provide an update on MedX Health’s initiatives in Europe, Middle East & Africa

Tracy Weslosky · December 13, 2021

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services, and Naman Demaghlatrous, Managing Director, […]

MedX Health’s global sales team discuss the commercialization of their teledermatology screening platform across North America, Europe and the Middle East

Tracy Weslosky · December 08, 2021

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services, Naman Demaghlatrous, Managing Director, Europe, […]

MedX Health’s teledermatology platform brings healthcare to the fingertips of patients

Tracy Weslosky · December 08, 2021

In a recent InvestorIntel interview, Tracy Weslosky spoke with Mike Druhan, President of Dermatology Services and Naman Demaghlatrous, Managing Director, […]